Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000670

Director sold 31,992 shares at an average $16.56 ($529,938)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-07-11 Sale : show line 1 in the form −14,120 $16.52 $233,262 2,426,435 I
2017-07-12 Sale : show line 2 in the form −17,872 $16.60 $296,675 2,408,563 I
Open-market sales · 31,992 sh · avg $16.56 · $529,938
Loading xslF345X03/vonemster_fm4july112017.xml…